Pembrolizumab for locally advanced cervical cancer

Lancet. 2024 Nov 23;404(10467):2049. doi: 10.1016/S0140-6736(24)02228-1.

Authors

Mitchell Kamrava¹, Sushil Beriwal²

Affiliations

¹ Cedars-Sinai Medical Center, Los Angeles, CA 90048, USA. Electronic address: mitchell.kamrava@cshs.org.
² Allegheny Health Network, Pittsburgh, PA, USA.

PMID: 39580198
DOI: 10.1016/S0140-6736(24)02228-1

No abstract available

Publication types

Letter